ANGEL-ASPECT
2023
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct
In 456 Chinese patients with LVO and large ischaemic core, endovascular therapy improved the 90-day mRS distribution versus medical management.
Result
Efficacy: mRS shift at 90 daysGeneralised OR 1.37 (95% CI 1.11-1.69) · P = 0.004
Below 1 favours medical management, above 1 favours endovascular therapy.
The estimate refers to a different reading of the endpoint than the rates.
- Subtopic
- Large-core thrombectomy
- Design
- Multicentre RCT, China
- Relevance
- Supporting: context rather than must-know.
- Cited in
- AHA/ASA 2026 Stroke
- Source
- Huo X, et al. N Engl J Med. 2023;388(14):1272-1283.doi 10.1056/NEJMoa2213379
Discussion & critique
Confirms SELECT2: large-core trials redefine the lower limit of viable tissue.